Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar and Thalidomide with Chemotherapy in Advanced Colorectal Cancer
NCT02748772Phase 3Unknown
- Sponsor
- Hefei First People's Hospital
- Start
- Jan 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of endostar, thalidomide in colorectal cancer (CRC), sponsored by Hefei First People's Hospital. Status: unknown.
02
Drugs
endostarthalidomide
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT02748772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02748772.